| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 2.96M | — |
| Operating expense | — | — |
| Net income | -23.79M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ARCT returned -27.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +119.4% |
| 1 year | -27.3% |
| 5 years | -75.5% |
| 10 years | -60.9% |
| All-time high | $166.67 (Feb 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ARCT would be worth today ›No. Arcturus Therapeutics Holdings Inc. has not paid a dividend in the past 12 months.
Arcturus Therapeutics Holdings Inc. stock trades on NASDAQ under the ticker symbol ARCT.
Arcturus Therapeutics Holdings Inc. is part of the Healthcare sector.
Arcturus Therapeutics Holdings Inc. has a market cap of 382.29M USD, based on the latest quote.
